GLOBUS MEDICAL INC 8-K

What Happened

• On January 7, 2026, Globus Medical, Inc. announced preliminary unaudited net sales results for the three-month period and fiscal year ended December 31, 2025, and also issued preliminary guidance for certain financial measures for the fiscal year ending December 31, 2026. The company furnished a press release as Exhibit 99.1 to the Form 8-K. The report was signed by Kyle Kline, Chief Financial Officer.

Key Details

• Filing date: January 7, 2026 (Form 8-K, Item 2.02).
• Results disclosed: preliminary unaudited net sales for Q4 and full-year 2025 (specific dollar amounts not included in the 8-K text).
• Guidance disclosed: preliminary guidance for certain 2026 financial measures (details provided in the press release exhibit).
• Press release furnished as Exhibit 99.1 and incorporated by reference.

Why It Matters

• Investors get an early look at Globus Medical’s revenue trends for Q4 and FY2025 and initial expectations for 2026. Because the figures are preliminary and unaudited, they may be revised when full audited results or a complete earnings release are published. Review the company’s press release (Exhibit 99.1) and subsequent filings for the full numbers, final results, and any management commentary to assess impact on revenue growth and near-term outlook.